EUVIMEDEUVIMED entdecken
Crossref

Highly Selective Inhibitors of Dipeptidyl Peptidase 9 (DPP9) Derived from the Clinically Used DPP4-Inhibitor Vildagliptin

Siham Benramdane, Joni De Loose, Nicolò Filippi, Margarida Espadinha, Olivier Beyens, Yentl Van Rymenant, Laura Dirkx, Murat Bozdag, Pim-Bart Feijens, Koen Augustyns iD, Guy Caljon, Hans De Winter iD und 2 weitere

Journal of Medicinal Chemistry · 2023

DOI: 10.1021/acs.jmedchem.3c00609 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2023. Verfasst von Siham Benramdane und 13 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Medicinal Chemistry, Department of Pharmaceutical Sciences, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium. Hauptthemen laut MEDLINE: Dipeptidyl-Peptidases and Tripeptidyl-Peptidases, Vildagliptin. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Fonds Wetenschappelijk Onderzoek.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dipeptidyl peptidase 9 (DPP9) is a proline-selective serine protease that plays a key role in NLRP1- and CARD8-mediated inflammatory cell death (pyroptosis). No selective inhibitors have hitherto been reported for the enzyme: all published molecules have grossly comparable affinities for DPP8 and 9 because of the highly similar architecture of these enzymes' active sites. Selective DPP9 inhibitors would be highly instrumental to address unanswered research questions on the enzyme's role in pyroptosis, and they could also be investigated as therapeutics for acute myeloid leukemias. Compounds presented in this manuscript (42 and 47) combine low nanomolar DPP9 affinities with unprecedented DPP9-to-DPP8 selectivity indices up to 175 and selectivity indices >1000 toward all other proline-selective proteases. To rationalize experimentally obtained data, a molecular dynamics study was performed. We also provide in vivo pharmacokinetics data for compound 42.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesVildagliptinDipeptidyl Peptidase 4Dipeptidyl-Peptidase IV InhibitorsProlineProtease InhibitorsSerine Endopeptidases

Substanzen

Dipeptidyl Peptidase 4Dipeptidyl-Peptidase IV InhibitorsDipeptidyl-Peptidases and Tripeptidyl-PeptidasesProlineProtease InhibitorsSerine EndopeptidasesVildagliptinDPP9 protein, human

Autor:innen und Institutionen

  • Laboratory of Medicinal Chemistry, Department of Pharmaceutical Sciences, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium.
  • Laboratory of Medical Biochemistry, Department of Pharmaceutical Sciences, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium.
  • Laboratory of Microbiology, Parasitology and Hygiene, Department of Biomedical Sciences, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium.

ORCID-Profile: Koen Augustyns, Hans De Winter, Pieter Van der Veken

Förderung

  • Fonds Wetenschappelijk Onderzoek

Zitieren

APA

Benramdane, S., De Loose, J., Filippi, N., Espadinha, M., Beyens, O., Rymenant, Y. V., Dirkx, L., Bozdag, M., Feijens, P. B., Augustyns, K., Caljon, G., De Winter, H., De Meester, I., & Van der Veken, P. (2023). Highly Selective Inhibitors of Dipeptidyl Peptidase 9 (DPP9) Derived from the Clinically Used DPP4-Inhibitor Vildagliptin. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.3c00609

Vancouver

Benramdane S, De Loose J, Filippi N, Espadinha M, Beyens O, Rymenant YV, et al. Highly Selective Inhibitors of Dipeptidyl Peptidase 9 (DPP9) Derived from the Clinically Used DPP4-Inhibitor Vildagliptin. Journal of Medicinal Chemistry. 2023. doi:10.1021/acs.jmedchem.3c00609

BibTeX
@article{Benramdane2023,
  author = {Benramdane, Siham and De Loose, Joni and Filippi, Nicolò and Espadinha, Margarida and Beyens, Olivier and Rymenant, Yentl Van and Dirkx, Laura and Bozdag, Murat and Feijens, Pim-Bart and Augustyns, Koen and Caljon, Guy and De Winter, Hans and De Meester, Ingrid and Van der Veken, Pieter},
  title = {Highly Selective Inhibitors of Dipeptidyl Peptidase 9 (DPP9) Derived from the Clinically Used DPP4-Inhibitor Vildagliptin},
  journal = {Journal of Medicinal Chemistry},
  year = {2023},
  doi = {10.1021/acs.jmedchem.3c00609}
}
Kostenlos starten →